Ameritas Investment Partners’s Syndax Pharmaceuticals SNDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $177K | Buy |
8,081
+962
| +14% | +$20K | ﹤0.01% | 1475 |
|
|
2026
Q1 | $166K | Hold |
7,119
| – | – | 0.01% | 1381 |
|
|
2025
Q4 | $150K | Hold |
7,119
| – | – | ﹤0.01% | 1443 |
|
|
2025
Q3 | $110K | Sell |
7,119
-739
| -9% | -$9.67K | ﹤0.01% | 1634 |
|
|
2025
Q2 | $73.6K | Hold |
7,858
| – | – | ﹤0.01% | 1943 |
|
|
2025
Q1 | $96.5K | Hold |
7,858
| – | – | ﹤0.01% | 1734 |
|
|
2024
Q4 | $104K | Hold |
7,858
| – | – | ﹤0.01% | 1753 |
|
|
2024
Q3 | $151K | Hold |
7,858
| – | – | ﹤0.01% | 1516 |
|
|
2024
Q2 | $161K | Hold |
7,858
| – | – | 0.01% | 1413 |
|
|
2024
Q1 | $187K | Buy |
7,858
+1,312
| +20% | +$29.3K | 0.01% | 1335 |
|
|
2023
Q4 | $141K | Hold |
6,546
| – | – | 0.01% | 1501 |
|
|
2023
Q3 | $95K | Buy |
6,546
+1,105
| +20% | +$20.9K | ﹤0.01% | 1691 |
|
|
2023
Q2 | $114K | Buy |
5,441
+609
| +13% | +$12.7K | ﹤0.01% | 1501 |
|
|
2023
Q1 | $102K | Buy |
4,832
+907
| +23% | +$22.6K | ﹤0.01% | 1525 |
|
|
2022
Q4 | $104K | Hold |
3,925
| – | – | ﹤0.01% | 1575 |
|
|
2022
Q3 | $94K | Buy |
3,925
+400
| +11% | +$8.97K | ﹤0.01% | 1533 |
|
|
2022
Q2 | $67K | Hold |
3,525
| – | – | ﹤0.01% | 1798 |
|
|
2022
Q1 | $61K | Hold |
3,525
| – | – | ﹤0.01% | 1941 |
|
|
2021
Q4 | $77K | Hold |
3,525
| – | – | ﹤0.01% | 1846 |
|
|
2021
Q3 | $67K | Hold |
3,525
| – | – | ﹤0.01% | 1963 |
|
|
2021
Q2 | $61K | Buy |
3,525
+1,145
| +48% | +$21K | ﹤0.01% | 2061 |
|
|
2021
Q1 | $53K | Hold |
2,380
| – | – | ﹤0.01% | 2053 |
|
|
2020
Q4 | $53K | Hold |
2,380
| – | – | ﹤0.01% | 1960 |
|
|
2020
Q3 | $35K | Hold |
2,380
| – | – | ﹤0.01% | 2056 |
|
|
2020
Q2 | $35K | Buy |
2,380
+579
| +32% | +$8.82K | ﹤0.01% | 2048 |
|
|
2020
Q1 | $20K | Buy |
1,801
+801
| +80% | +$7.52K | ﹤0.01% | 2190 |
|
|
2019
Q4 | $9K | Hold |
1,000
| – | – | ﹤0.01% | 2780 |
|
|
2019
Q3 | $7K | Hold |
1,000
| – | – | ﹤0.01% | 2855 |
|
|
2019
Q2 | $9K | Hold |
1,000
| – | – | ﹤0.01% | 2834 |
|
|
2019
Q1 | $5K | Hold |
1,000
| – | – | ﹤0.01% | 2863 |
|
|
2018
Q4 | $4K | Hold |
1,000
| – | – | ﹤0.01% | 2892 |
|
|
2018
Q3 | $8K | Hold |
1,000
| – | – | ﹤0.01% | 2895 |
|
|
2018
Q2 | $7K | Hold |
1,000
| – | – | ﹤0.01% | 2899 |
|
|
2018
Q1 | $14K | Buy |
1,000
+633
| +172% | +$6.72K | ﹤0.01% | 2603 |
|
|
2017
Q4 | $3K | Hold |
367
| – | – | ﹤0.01% | 2917 |
|
|
2017
Q3 | $4K | Hold |
367
| – | – | ﹤0.01% | 2943 |
|
|
2017
Q2 | $5K | Hold |
367
| – | – | ﹤0.01% | 2939 |
|
|
2017
Q1 | $5K | Buy |
+367
| New | +$3.81K | ﹤0.01% | 2844 |
|
Other funds holding SNDX
KCM
DM
EP
HRCM
Ameritas Investment Partners's SNDX Position: Q2 2026 in Review
Ameritas Investment Partners increased its Syndax Pharmaceuticals (SNDX) stake by 14% in Q2 2026, buying an estimated $20K and bringing the position to 8,081 shares worth $177K. The position accounts for ﹤0.01% of the portfolio, ranked #1475.
Ameritas Investment Partners first reported a position in SNDX in Q1 2017 and has held it in 38 quarters since. The position peaked at $187K in Q1 2024. 242 funds tracked by Wall St. Rank hold SNDX as of Q2 2026.
- Ameritas Investment Partners held 8,081 shares of Syndax Pharmaceuticals worth $177K as of Q2 2026.
- Ameritas Investment Partners bought 962 Syndax Pharmaceuticals shares in Q2 2026, an estimated $20K.
- Syndax Pharmaceuticals made up ﹤0.01% of Ameritas Investment Partners's portfolio in Q2 2026, its #1475 holding.
- Ameritas Investment Partners first reported a position in Syndax Pharmaceuticals in Q1 2017 and has held it in 38 quarters since.
- Ameritas Investment Partners's Syndax Pharmaceuticals position peaked at $187K in Q1 2024.
- 242 funds tracked by Wall St. Rank held Syndax Pharmaceuticals as of Q2 2026.
Based on Ameritas Investment Partners's 13F filing for Q2 2026, filed 13 Aug 2026.